News

October 31, 2023

|

Category:

Condensate-targeted drug discovery powered by phenotypic signatures

Poster presented at the Society of Biomolecular Imaging and Informatics (SBI2) 10th Annual Conference

> Download the PDF file

Media Contact

media@dewpointx.com

Investor Contact

Scott Peterson, Ph.D.

SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
speterson@dewpointx.com

Back to News home section

Share:

Advancing basic condensate science towards drugging the undruggable

Rare missense variants in protein intrinsically disordered regions: impact on condensates and common diseases

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA

Home About us Science Pipeline Join us News Contact

Condensates.com

© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science